Graf Akcie IRWD (Ironwood Pharmaceuticals Inc). Diskuze k akciím IRWD. Aktuální informace IRWD.

Základní informace o společnosti Ironwood Pharmaceuticals Inc (Akcie IRWD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.23B
Hodnota podniku (EV) 2.01B
Tržby 413.024M
EBITDA 225.955M
Zisk 508.856M
Růst v tržbách Q/Q 16.32 %
Růst v tržbách Y/Y -3.24 %
P/E (Cena vůči ziskům) 4.32
Forward P/E N/A
EV/Sales 4.87
EV/EBITDA 8.91
EV/EBIT 9.80
PEG 0.25
Price/Sales 5.40
P/FCF 9.81
Price/Book 35.60
Účetní hodnota na akcii 0.38
Hotovost na akcii 2.23
FCF vůči ceně 10.20 %
Počet zaměstnanců 232
Tržba na zaměstnance 1780000
Profit margin 27.26 %
Operating margin 50.24 %
Gross margin 99.19 %
EBIT margin 49.72 %
EBITDA margin 54.71 %
EPS - Zisk na akcii 3.16
EPS - Kvartální růst 112.50 %
EPS - Očekávaný růst příští rok 21.74 %
Return on assets 76.57 %
Return on equity 294.78 %
ROIC 28.76 %
ROCE 23.53 %
Dluhy/Equity 7.93
Čistý dluh/EBITDA 1.13
Current ratio 4.62
Quick Ratio 4.62
Volatilita 2.75
Beta 0.60
RSI 58.22
Cílová cena analytiků 11
Známka akcie (dle analytiků) 2.67
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 162.895M
Procento shortovaných akcií 21.74 %
Short ratio 11.04 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2010
Země United States

Finanční výsledky akcie IRWD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$389.523$428.413$346.639$298.276$273.957$149.555
Cost Of Goods Sold$3.136$23.875$32.751$19.097$1.868$0.012
Gross Profit$386.387$404.538$313.888$279.179$272.089$149.543
Research And Development Expenses$88.062$115.044$101.06$88.145$139.492$108.746
SG&A Expenses$140.003$172.45$219.676$231.184$173.281$125.247
Other Operating Income Or Expenses-$6.699$-120.996$31.001$-10.205$-17.638
Operating Expenses$246.583$308.29$497.309$313.639$325.827$251.643
Operating Income$142.94$120.123$-150.67$-15.363$-51.87$-102.088
Total Non-Operating Income/Expense$-34.079$-61.18$-43.476$-39.552$-29.838$-40.581
Pre-Tax Income$108.861$58.943$-194.146$-54.915$-81.708$-142.669
Income Taxes$2.685-----
Income After Taxes$106.176$58.943$-194.146$-54.915$-81.708$-142.669
Other Income------
Income From Continuous Operations$106.176$58.943$-194.146$-54.915$-81.708$-142.669
Income From Discontinued Operations-$-37.438$-88.222$-62.022--
Net Income$106.176$21.505$-282.368$-116.937$-81.708$-142.669
EBITDA$146.504$125.703$-138.7$-2.707$-40.61$-90.458
EBIT$142.94$120.123$-150.67$-15.363$-51.87$-102.088
Basic Shares Outstanding159156153149145142
Shares Outstanding161156153149145142
Basic EPS$0.67$0.14$-1.85$-0.78$-0.56$-1.00
EPS - Earnings Per Share$0.66$0.14$-1.85$-0.78$-0.56$-1.00
# 2020 2019 2018 2017 2016 2015
Current Ratio15.41177.49722.22914.71924.17186.5416
Long-term Debt / Capital0.87291.29632.15560.97570.8460.7881
Debt/Equity Ratio6.8687-4.3752-2.107940.63455.58794.0104
Gross Margin99.194994.427190.551893.597599.318199.992
Operating Margin36.696228.0391-43.466-5.1506-18.9336-68.2612
EBIT Margin36.696228.0391-43.466-5.1506-18.9336-68.2612
EBITDA Margin37.611129.3415-40.0128-0.9076-14.8235-60.4848
Pre-Tax Profit Margin27.947313.7585-56.0081-18.4108-29.8251-95.3957
Net Profit Margin27.2585.0197-81.4588-39.2043-29.8251-95.3957
Asset Turnover0.69651.06371.04390.49250.3860.2416
Inventory Turnover Ratio-36.8441-25.98231.728-
Receiveable Turnover3.18373.6544.28213.63064.22422.7432
Days Sales In Receivables114.648299.891485.2378100.535486.4067133.0552
ROE - Return On Equity169.5019-63.208998.867-557.6258-122.4716-149.9807
Return On Tangible Equity169.502-63.20998.473336.405781.5547-149.9806
ROA - Return On Assets18.985814.6352-58.4689-9.0668-11.5111-23.0438
ROI - Return On Investment21.541318.7273-114.2539-13.5279-18.8576-31.7738
Book Value Per Share0.39-0.5919-1.27170.06550.45350.6641
Operating Cash Flow Per Share0.98220.53310.2118-0.49730.57330.3849
Free Cash Flow Per Share1.01510.48090.2376-0.48770.57320.3834